Citations (705)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (34)
Lijun Feng, Chuance Sun, Xiaohua Sun, Yang Zhao, Rilei Yu & Congmin Kang. (2021) Identification of inhibitors targeting HIF-2α/c-Myc by molecular docking and MM-GBSA technology. Journal of Receptors and Signal Transduction 41:5, pages 511-519.
Read now
Read now
Elshad Hasanov & Eric Jonasch. (2021) MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma. Expert Opinion on Investigational Drugs 30:5, pages 495-504.
Read now
Read now
Kaleemullah B. Khan, L. Praba & H. Abdul Jaffar Ali. (2020) Biological identification of ascidians from Vizhinjam Bay, southwest Coast of India using CO1 gene sequences. Mitochondrial DNA Part A 31:5, pages 209-217.
Read now
Read now
Christina Wohlrab, Caroline Kuiper, Margreet CM Vissers, Elisabeth Phillips, Bridget A Robinson & Gabi U Dachs. (2019) Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells. Hypoxia 7, pages 17-31.
Read now
Read now
Najah Albadari, Shanshan Deng & Wei Li. (2019) The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opinion on Drug Discovery 14:7, pages 667-682.
Read now
Read now
Jianping Guo & Wenyi Wei. (2019) Fine-tuning AKT kinase activity through direct lysine methylation. Cell Cycle 18:9, pages 917-922.
Read now
Read now
Kellsye Paula L. Fabian, Nina Chi-Sabins, Jennifer L. Taylor, Ronald Fecek, Aliyah Weinstein & Walter J. Storkus. (2017) Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice. OncoImmunology 6:3.
Read now
Read now
Daniel Triner, Xiang Xue, Andrew J. Schwartz, Inkyung Jung, Justin A. Colacino & Yatrik M. Shah. (2017) Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils. Molecular and Cellular Biology 37:5.
Read now
Read now
Sebastiano Buti, Alessandro Leonetti, Alice Dallatomasina & Melissa Bersanelli. (2016) Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy. Core Evidence 11, pages 23-36.
Read now
Read now
Marina D Hendrickson & Robert O Poyton. (2015) Crosstalk between nitric oxide and hypoxia-inducible factor signaling pathways: an update. Research and Reports in Biochemistry 5, pages 147-161.
Read now
Read now
Yuhan Chen, Gang Xu, Yi Zheng, Maosheng Yan, Zihuang Li, Yayan Zhou, Lin Mei & Xianming Li. (2015) Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapy. International Journal of Nanomedicine 10, pages 1375-1386.
Read now
Read now
Jae-Jun Ban, Robin J Ruthenborg, Kevin W Cho & Jung-whan Kim. (2014) Regulation of obesity and insulin resistance by hypoxia-inducible factors. Hypoxia 2, pages 171-183.
Read now
Read now
Jerry H Fuady, Mattia R Bordoli, Irene Abreu-Rodríguez, Glen Kristiansen, David Hoogewijs, Daniel P Stiehl & Roland H Wenger. (2014) Hypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer. Hypoxia 2, pages 23-33.
Read now
Read now
Patricia Denise Tiburcio, Hyunsung Choi & L Eric Huang. (2014) Complex role of HIF in cancer: the known, the unknown, and the unexpected. Hypoxia 2, pages 59-70.
Read now
Read now
Neil J Howell & Daniel A Tennant. (2014) The role of HIFs in ischemia-reperfusion injury. Hypoxia 2, pages 107-115.
Read now
Read now
Tammie Bishop & Peter J Ratcliffe. (2014) Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives. Hypoxia 2, pages 197-213.
Read now
Read now
Zhu Chen, Xing Liu, Zhichao Mei, Zhou Wang & Wuhan Xiao. (2014) EAF2 Suppresses Hypoxia-Induced Factor 1α Transcriptional Activity by Disrupting Its Interaction with Coactivator CBP/p300. Molecular and Cellular Biology 34:6, pages 1085-1099.
Read now
Read now
Johnny A. Sena, Liyi Wang & Cheng-Jun Hu. (2013) BRG1 and BRM Chromatin-Remodeling Complexes Regulate the Hypoxia Response by Acting as Coactivators for a Subset of Hypoxia-Inducible Transcription Factor Target Genes. Molecular and Cellular Biology 33:19, pages 3849-3863.
Read now
Read now
Matthew R. Pawlus, Liyi Wang, Katie Ware & Cheng-Jun Hu. (2012) Upstream Stimulatory Factor 2 and Hypoxia-Inducible Factor 2α (HIF2α) Cooperatively Activate HIF2 Target Genes during Hypoxia. Molecular and Cellular Biology 32:22, pages 4595-4610.
Read now
Read now
Barbara Chiavarina, Ubaldo E. Martinez-Outschoorn, Diana Whitaker-Menezes, Anthony Howell, Herbert B. Tanowitz, Richard G. Pestell, Federica Sotgia & Michael P. Lisanti. (2012) Metabolic reprogramming and two-compartment tumor metabolism. Cell Cycle 11:17, pages 3280-3289.
Read now
Read now
Aaishwarya B. Deshmukh, Jayvadan K. Patel, Ashish R. Prajapati & Shreya Shah. (2012) Perspective in Chronic Kidney Disease: Targeting Hypoxia-Inducible Factor (HIF) as Potential Therapeutic Approach. Renal Failure 34:4, pages 521-532.
Read now
Read now
Dylan T Jones & Adrian L Harris. (2012) Small-molecule inhibitors of the HIF pathway and synthetic lethal interactions. Expert Opinion on Therapeutic Targets 16:5, pages 463-480.
Read now
Read now
Autumn L Jackson, Bing Zhou & William Y Kim. (2010) HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer. Expert Opinion on Therapeutic Targets 14:10, pages 1047-1057.
Read now
Read now
Scott M. Welford, Mary Jo Dorie, Xiaofeng Li, Volker H. Haase & Amato J. Giaccia. (2010) Renal Oxygenation Suppresses VHL Loss-Induced Senescence That Is Caused by Increased Sensitivity to Oxidative Stress. Molecular and Cellular Biology 30:19, pages 4595-4603.
Read now
Read now
Adam J. Krieg, Erinn B. Rankin, Denise Chan, Olga Razorenova, Sully Fernandez & Amato J. Giaccia. (2010) Regulation of the Histone Demethylase JMJD1A by Hypoxia-Inducible Factor 1α Enhances Hypoxic Gene Expression and Tumor Growth. Molecular and Cellular Biology 30:1, pages 344-353.
Read now
Read now
Peter Ebbesen, Erik O. Pettersen, Thomas A. Gorr, Gerhard Jobst, Kaye Williams, Jochen Kieninger, Roland H. Wenger, Silvia Pastorekova, Ludwig Dubois, Philippe Lambin, Brad G. Wouters, Twan Van Den Beucken, Claudiu T. Supuran, Lorenz Poellinger, Peter Ratcliffe, Arvydas Kanopka, Agnes Görlach, Max Gasmann, Adrian L. Harris, Patrick Maxwell & Andrea Scozzafava. (2009) Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. Journal of Enzyme Inhibition and Medicinal Chemistry 24:sup1, pages 1-39.
Read now
Read now
Johanna Sandlund, Börje Ljungberg, Pernilla Wikström, Kjell Grankvist, Gudrun Lindh & Torgny Rasmuson. (2009) Hypoxia-inducible factor-2α mRNA expression in human renal cell carcinoma. Acta Oncologica 48:6, pages 909-914.
Read now
Read now
Mei Yee Koh, Bryant G. Darnay & Garth Powis. (2008) Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation . Molecular and Cellular Biology 28:23, pages 7081-7095.
Read now
Read now
W Kimryn Rathmell & Shufen Chen. (2008) VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment. Expert Review of Anticancer Therapy 8:1, pages 63-73.
Read now
Read now
Lianjie Li, Liang Zhang, Xiaoping Zhang, Qin Yan, Yoji Andrew Minamishima, Aria F. Olumi, Mao Mao, Steven Bartz & William G. Kaelin$suffix/text()$suffix/text(). (2007) Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations. Molecular and Cellular Biology 27:15, pages 5381-5392.
Read now
Read now
Qin Yan, Steven Bartz, Mao Mao, Lianjie Li & William G. Kaelin$suffix/text()$suffix/text(). (2007) The Hypoxia-Inducible Factor 2α N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo. Molecular and Cellular Biology 27:6, pages 2092-2102.
Read now
Read now
Cheng-Jun Hu, Sangeeta Iyer, Aneesa Sataur, Kelly L. Covello, Lewis A. Chodosh & M. Celeste Simon. (2006) Differential Regulation of the Transcriptional Activities of Hypoxia-Inducible Factor 1 Alpha (HIF-1α) and HIF-2α in Stem Cells. Molecular and Cellular Biology 26:9, pages 3514-3526.
Read now
Read now
Gregg L Semenza. (2006) Development of novel therapeutic strategies that target HIF-1. Expert Opinion on Therapeutic Targets 10:2, pages 267-280.
Read now
Read now
Thambi Dorai, Ihor Sawczuk, Jaromir Pastorek, Peter H. Wiernik & Janice P. Dutcher. (2006) Role of Carbonic Anhydrases in the Progression of Renal Cell Carcinoma Subtypes: Proposal of a Unified Hypothesis. Cancer Investigation 24:8, pages 754-779.
Read now
Read now
Articles from other publishers (671)
Sarah E. Lacher, Cara Skon-Hegg, Brian L. Ruis, Jennifer Krznarich & Matthew Slattery. (2023) An antioxidant response element regulates the HIF1α axis in breast cancer cells. Free Radical Biology and Medicine 204, pages 243-251.
Crossref
Crossref
Yue Zhang, Catherine C Nguyen, Nigel T Zhang, Nicolas S Fink, Jordan D John, Omkar G Venkatesh, Jonathan D Roe, Steven C Hoffman, Maciej S Lesniak, Jean-Paul Wolinsky, Craig Horbinski, Brittany M Szymaniak, Robin A Buerki, Jeffrey A Sosman, Niraj K Shenoy & Rimas V Lukas. (2023) Neurological applications of belzutifan in von Hippel-Lindau disease. Neuro-Oncology 25:5, pages 827-838.
Crossref
Crossref
Limei Li, Jun Zhao, Haishan Zhang, Danping Li, Shu Wu, Wenqing Xu, Xinli Pan, Wenjin Hu, Jiemei Chu, Wenqi Luo, Ping Li & Xiaoying Zhou. (2023) HIGD1A inactivated by DNA hypermethylation promotes invasion of kidney renal clear cell carcinoma. Pathology - Research and Practice 245, pages 154463.
Crossref
Crossref
Junhui Hu, Ping Tan, Moe Ishihara, Nicholas A. Bayley, Shiruyeh Schokrpur, Jeremy G. Reynoso, Yangjun Zhang, Raymond J. Lim, Camelia Dumitras, Lu Yang, Steven M. Dubinett, Parmjit S. Jat, Jacques Van Snick, Jiaoti Huang, Arnold I. Chin, Robert M. Prins, Thomas G. Graeber, Hua Xu & Lily Wu. (2023) Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Véronique N Lafleur, Silvia Halim, Hani Choudhry, Peter J Ratcliffe & David R Mole. (2023) Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma. Life Science Alliance 6:4, pages e202201756.
Crossref
Crossref
Hajime Takamori, Toshinari Yamasaki, Rui Kitadai, Yoji Andrew Minamishima & Eijiro Nakamura. (2023)
Development of drugs targeting hypoxia‐inducible factor against tumor cells with
VHL
mutation: Story of 127 years
. Cancer Science 114:4, pages 1208-1217.
Crossref
Crossref
Tewodros Shibabaw, Banchamlak Teferi & Birhanu Ayelign. (2023) The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target. Frontiers in Immunology 14.
Crossref
Crossref
Luciana Mastrodomenico, Claudia Piombino, Beatrice Riccò, Elena Barbieri, Marta Venturelli, Federico Piacentini, Massimo Dominici, Laura Cortesi & Angela Toss. (2023) Personalized Systemic Therapies in Hereditary Cancer Syndromes. Genes 14:3, pages 684.
Crossref
Crossref
Sonia Mazumder, Paul J. Higgins & Rohan Samarakoon. (2023) Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance. Cancers 15:4, pages 1316.
Crossref
Crossref
Youcef M. Rustum, Ryan Reis & Tara M. Rustum. (2023) Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy. International Journal of Molecular Sciences 24:2, pages 902.
Crossref
Crossref
Sze Kiat Tan, Helen Y. Hougen, Jaime R. Merchan, Mark L. Gonzalgo & Scott M. Welford. (2022) Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets. Nature Reviews Urology 20:1, pages 48-60.
Crossref
Crossref
Stephen Norda & Rosa Papadantonaki. (2023) Regulation of cells of the arterial wall by hypoxia and its role in the development of atherosclerosis. Vasa 52:1, pages 6-21.
Crossref
Crossref
Snigdha Sarkar, Shreya Sinha, Rohit Saluja & Neetu Kalra. 2023. Hypoxia in Cancer: Significance and Impact on Cancer Therapy. Hypoxia in Cancer: Significance and Impact on Cancer Therapy
403
432
.
Rashmi Supriya, Kumar Purnendu Singh, Yang Gao, Dan Tao, Sarah Cheour, Frederic Dutheil & Julien S. Baker. (2022) Mimicking Gene–Environment Interaction of Higher Altitude Dwellers by Intermittent Hypoxia Training: COVID-19 Preventive Strategies. Biology 12:1, pages 6.
Crossref
Crossref
Noah Trac, Hyun Seok Oh, Leila Izzy Jones, Randy Caliliw, Shinji Ohtake, Brian Shuch & Eun Ji Chung. (2022) CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells. Molecules 27:23, pages 8457.
Crossref
Crossref
Jia-Ming Wang, Zhen-Fang Li, Wan-Xi Yang & Fu-Qing Tan. (2022) Follicle-stimulating hormone signaling in Sertoli cells: a licence to the early stages of spermatogenesis. Reproductive Biology and Endocrinology 20:1.
Crossref
Crossref
Yu Chen, Claudia Cattoglio, Gina M Dailey, Qiulin Zhu, Robert Tjian & Xavier Darzacq. (2022) Mechanisms governing target search and binding dynamics of hypoxia-inducible factors. eLife 11.
Crossref
Crossref
Lauren E. Langbein, Rayan El Hajjar, William Y. Kim & Haifeng Yang. (2022) The convergence of tumor suppressors on the type I interferon pathway in clear cell renal cell carcinoma and its therapeutic implications. American Journal of Physiology-Cell Physiology 323:5, pages C1417-C1429.
Crossref
Crossref
Grégoire P. Millet, Martin Burtscher & Johannes Burtscher. (2021) Is Hypoxic/Altitude Training an Important Topic in the Field of Hypoxia?. Journal of Science in Sport and Exercise 4:4, pages 293-305.
Crossref
Crossref
Gaelan Melanson, Antonia C. Du Bois, Caroline Webster & James Uniacke. (2022)
ISGylation
directly modifies hypoxia‐inducible factor‐2α and enhances its polysome association
. FEBS Letters 596:21, pages 2834-2850.
Crossref
Crossref
Moon Hee Lee, Kyung Sung, David Beebe, Wei Huang, Dan Shapiro, Shigeki Miyamoto & E. Jason Abel. (2022) The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells. Oncogenesis 11:1.
Crossref
Crossref
Yangsook Song Green, Maria C. Ferreira dos Santos, Daniel G. Fuja, Ethan C. Reichert, Alexandre R. Campos, Sophie J. Cowman, Karen Acuña Pilarte, Jessica Kohan, Sheryl R. Tripp, Elizabeth A. Leibold, Deepika Sirohi, Neeraj Agarwal, Xiaohui Liu & Mei Yee Koh. (2022) ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma. Oncogene 41:42, pages 4709-4723.
Crossref
Crossref
Bing X. Ross, Lin Jia, Dejuan Kong, Tiantian Wang, Jingyu Yao, Heather M. Hager, Steven F. Abcouwer & David N. Zacks. (2022) Hypoxia-Inducible Factor-1α in Rods Is Neuroprotective Following Retinal Detachment. Investigative Opthalmology & Visual Science 63:11, pages 7.
Crossref
Crossref
Sylwia Bartoszewska, James F. Collawn & Rafal Bartoszewski. (2022) The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment. Cancers 14:19, pages 4870.
Crossref
Crossref
William G. KaelinJr.Jr.. (2022) Von Hippel–Lindau disease: insights into oxygen sensing, protein degradation, and cancer. Journal of Clinical Investigation 132:18.
Crossref
Crossref
Haibiao Xie, Jin Zhou, Xijuan Liu, Yawei Xu, Austin J. Hepperla, Jeremy M. Simon, Tao Wang, Hongwei Yao, Chengheng Liao, Albert S. Baldwin, Kan Gong & Qing Zhang. (2022) USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer. Proceedings of the National Academy of Sciences 119:36.
Crossref
Crossref
Valeria Manuelli, Chiara Pecorari, Giuseppe Filomeni & Ester Zito. (2021) Regulation of redox signaling in HIF‐1‐dependent tumor angiogenesis. The FEBS Journal 289:18, pages 5413-5425.
Crossref
Crossref
Yoichiro Sugimoto & Peter J. Ratcliffe. (2022) Isoform-resolved mRNA profiling of ribosome load defines interplay of HIF and mTOR dysregulation in kidney cancer. Nature Structural & Molecular Biology 29:9, pages 871-880.
Crossref
Crossref
Shiyu Qi, Shoulong Deng, Zhengxing Lian & Kun Yu. (2022) Novel Drugs with High Efficacy against Tumor Angiogenesis. International Journal of Molecular Sciences 23:13, pages 6934.
Crossref
Crossref
María Carcelen, Carlos Velasquez, Verónica Vidal, Olga Gutiérrez & José L. Fernández-Luna. (2022) Signaling Pathways Regulating the Expression of the Glioblastoma Invasion Factor TENM1. Biomedicines 10:5, pages 1104.
Crossref
Crossref
Laura W. D. Knijff, Cees van Kooten & Rutger J. Ploeg. (2022) The Effect of Hypothermic Machine Perfusion to Ameliorate Ischemia-Reperfusion Injury in Donor Organs. Frontiers in Immunology 13.
Crossref
Crossref
Laura A. Stransky, Sean M. Vigeant, Bofu Huang, Destiny West, Thomas Denize, Emily Walton, Sabina Signoretti & William G. KaelinJr.Jr.. (2022)
Sensitivity of
VHL
mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway
. Proceedings of the National Academy of Sciences 119:14.
Crossref
Crossref
Weixiao Huang, Xiong Liu, Yao Zhang, Mingxia Deng, Guangqiang Li, Guo Chen, Li Yu, Lai Jin, Tongzheng Liu, Yijie Wang & Yan Chen. (2022) USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α. Journal of Cellular Physiology 237:4, pages 2211-2219.
Crossref
Crossref
Anna Gluba-Brzózka, Jacek Rysz, Janusz Ławiński & Beata Franczyk. (2022) Renal Cell Cancer and Obesity. International Journal of Molecular Sciences 23:6, pages 3404.
Crossref
Crossref
Asmaa Aboelnaga, Eman Mansour, Asmaa M Fahim & Ghada H. Elsayed. (2022) Synthesis, anti-proliferative activity, gene expression, docking and DFT investigation of novel pyrazol-1-yl-thiazol-4(5H)-one derivatives. Journal of Molecular Structure 1251, pages 131945.
Crossref
Crossref
Johanna Protze, Stephanie Naas, René Krüger, Christine Stöhr, Andre Kraus, Steffen Grampp, Michael Wiesener, Mario Schiffer, Arndt Hartmann, Bernd Wullich & Johannes Schödel. (2022) The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression. Journal of Biological Chemistry 298:3, pages 101699.
Crossref
Crossref
Philip J. Medeiros, Sydney A. Pascetta, Sarah M. Kirsh, Baraa K. Al-Khazraji & James Uniacke. (2022) Expression of hypoxia inducible factor–dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation. Journal of Biological Chemistry 298:3, pages 101645.
Crossref
Crossref
Silvia Ribback, Stefan Winter, Tobias Klatte, Elke Schaeffeler, Manuela Gellert, Viktoria Stühler, Marcus Scharpf, Jens Bedke, Martin Burchardt, Matthias Schwab, Christopher H. Lillig & Nils Kroeger. (2021) Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC. World Journal of Urology 40:3, pages 739-746.
Crossref
Crossref
Leah Davis, Matthias Recktenwald, Evan Hutt, Schuyler Fuller, Madison Briggs, Arnav Goel & Nichole Daringer. (2022) Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy. Cancers 14:5, pages 1259.
Crossref
Crossref
Karolina Hanusek, Beata Rybicka, Piotr Popławski, Anna Adamiok‑Ostrowska, Katarzyna Głuchowska, Agnieszka Piekiełko‑witkowska & Joanna Bogusławska. (2022) TGF‑β1 affects the renal cancer miRNome and regulates tumor cells proliferation. International Journal of Molecular Medicine 49:4.
Crossref
Crossref
Kai Guo, Yinghua Wei, Ze Wang, Xiaoli Zhang, Xin Zhang, Xinxin Liu, Wenyong Wu, Zhengsheng Wu, Lingqiang Zhang & Chun-Ping Cui. (2022) Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma. Cell Death & Disease 13:2.
Crossref
Crossref
Aleksandra Cabaj, Adrianna Moszyńska, Agata Charzyńska, Rafał Bartoszewski & Michał Dąbrowski. (2022) Functional and HRE motifs count analysis of induction of selected hypoxia-responsive genes by HIF-1 and HIF-2 in human umbilical endothelial cells. Cellular Signalling 90, pages 110209.
Crossref
Crossref
Xuechun Wang, Jin Hu, Yihao Fang, Yanbin Fu, Bing Liu, Chao Zhang, Shan Feng & Xin Lu. (2022) Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines. Cells 11:3, pages 472.
Crossref
Crossref
Xinglu Chen, Xiangsheng Cai, Dianpeng Zheng, Xiuya Huang, Ying Chen, Tanggang Deng, Lijun Mo, Hongwei Li, Jinlong Li & Sansan Chen. (2021) Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro. Anti-Cancer Drugs 33:1, pages e94-e102.
Crossref
Crossref
Sophie J. Cowman & Mei Yee Koh. (2022) Revisiting the HIF switch in the tumor and its immune microenvironment. Trends in Cancer 8:1, pages 28-42.
Crossref
Crossref
Kannappan Sriramajayam, Ravindran Caspa Gokulan & Jayaraman Tharmalingam. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
4003
4021
.
Kannappan Sriramajayam, Ravindran Caspa Gokulan & Jayaraman Tharmalingam. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
19
.
Elisabetta Iessi, Rosa Vona, Camilla Cittadini & Paola Matarrese. (2021) Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path. Biomedicines 9:12, pages 1942.
Crossref
Crossref
Olivia Lombardi & David Robert Mole. 2021. Biomarkers and Bioanalysis Overview. Biomarkers and Bioanalysis Overview.
Esther Arnaiz, Ana Miar, Esther Bridges, Naveen Prasad, Stephanie B. Hatch, Daniel Ebner, Charles H. Lawrie & Adrian L. Harris. (2021) Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs. BMC Cancer 21:1.
Crossref
Crossref
Aleša Kristan, Nataša Debeljak & Tanja Kunej. (2021) Integration and Visualization of Regulatory Elements and Variations of the EPAS1 Gene in Human. Genes 12:11, pages 1793.
Crossref
Crossref
Liesl K. Janssens & Christophe P. Stove. (2021) Sensing an Oxygen Sensor: Development and Application of Activity-Based Assays Directly Monitoring HIF Heterodimerization. Analytical Chemistry 93:43, pages 14462-14470.
Crossref
Crossref
Eleonora A. Braga, Marina V. Fridman, Elena A. Filippova, Vitaly I. Loginov, Irina V. Pronina, Alexey M. Burdennyy, Alexander V. Karpukhin, Alexey A. Dmitriev & Sergey G. Morozov. (2021) LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences 22:20, pages 11193.
Crossref
Crossref
Yaroslava Karpova, Danping Guo, Peter Makhov, Adam Haines, Dmitriy Markov, Vladimir Kolenko & Alexei Tulin. (2021) Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy. Cancers 13:19, pages 4973.
Crossref
Crossref
Ain Zubaidah Ayob & Thamil Selvee Ramasamy. (2021) Prolonged hypoxia switched on cancer stem cell-like plasticity in HepG2 tumourspheres cultured in serum-free media. In Vitro Cellular & Developmental Biology - Animal 57:9, pages 896-911.
Crossref
Crossref
Rouven Hoefflin, Sabine Harlander, Behnaz A. Abhari, Asin Peighambari, Mojca Adlesic, Philipp Seidel, Kyra Zodel, Stefan Haug, Burulca Göcmen, Yong Li, Bernd Lahrmann, Niels Grabe, Danijela Heide, Melanie Boerries, Anna Köttgen, Mathias Heikenwalder & Ian J. Frew. (2021) Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers 13:19, pages 4801.
Crossref
Crossref
Ming-xiao Zhang, Li-zhen Zhang, Liang-min Fu, Hao-hua Yao, Lei Tan, Zi-hao Feng, Jia-ying Li, Jun Lu, Yi-hui Pan, Guan-nan Shu, Peng-ju Li, Yi-ming Tang, Zhuang-yao Liao, Jin-huan Wei, Wei Chen, Jian-ping Guo, Jun-hang Luo & Zhen-hua Chen. (2021) Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis. Oncogene 40:37, pages 5639-5650.
Crossref
Crossref
María Armesto, Maitane Marquez, María Arestin, Peio Errarte, Ane Rubio, Lorea Manterola, Jose I. López & Charles H. Lawrie. (2021) Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC). Cancers 13:17, pages 4401.
Crossref
Crossref
Fengzhi Li, Ieman A. M. Aljahdali, Renyuan Zhang, Kent L. Nastiuk, John J. Krolewski & Xiang Ling. (2021) Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Karthikeyan Rajamani, Somasundaram S. Thirugnanasambandan, Chidambaram Natesan, Sethupathy Subramaniam, Balasubramanian Thangavel & Natarajan Aravindan. (2020) Squalene deters drivers of RCC disease progression beyond VHL status. Cell Biology and Toxicology 37:4, pages 611-631.
Crossref
Crossref
Mariela Beatriz Nolly, Lorena Alejandra Vargas, María Verónica Correa, Juan Manuel Lofeudo, Andrés Oscar Pinilla, Jorge Omar Velez Rueda, Martin E. Guerrero-Gimenez, Erik Richard Swenson, Maria Teresa Damiani & Bernardo Victor Alvarez. (2021) Carbonic anhydrase IX and hypoxia-inducible factor 1 attenuate cardiac dysfunction after myocardial infarction. Pflügers Archiv - European Journal of Physiology 473:8, pages 1273-1285.
Crossref
Crossref
Liang Wei, Na Yuan, Yingying Chen & Pingping Gong. (2021) Aberrant expression of HIF3A in plasma of patients with non‐small cell lung cancer and its clinical significance. Journal of Clinical Laboratory Analysis 35:8.
Crossref
Crossref
Jiangyi Wang, Yun Zou, Bowen Du, Wenzhi Li, Guopeng Yu, Long Li, Lin Zhou, Xin Gu, Shangqing Song, Yushan Liu, Wenquan Zhou, Bin Xu & Zhong Wang. (2021) SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155/HIF-1α signaling. Cell Death & Disease 12:7.
Crossref
Crossref
Maxwell Shulman, Rachel Shi & Qing Zhang. (2021) Von Hippel-Lindau tumor suppressor pathways & corresponding therapeutics in kidney cancer. Journal of Genetics and Genomics 48:7, pages 552-559.
Crossref
Crossref
Danchen Wu, Asish Dasgupta, Austin D. Read, Rachel E.T. Bentley, Mehras Motamed, Kuang-Hueih Chen, Ruaa Al-Qazazi, Jeffrey D. Mewburn, Kimberly J. Dunham-Snary, Elahe Alizadeh, Lian Tian & Stephen L. Archer. (2021) Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer. Free Radical Biology and Medicine 170, pages 150-178.
Crossref
Crossref
Vittoria Infantino, Anna Santarsiero, Paolo Convertini, Simona Todisco & Vito Iacobazzi. (2021) Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. International Journal of Molecular Sciences 22:11, pages 5703.
Crossref
Crossref
Eric Jonasch, Cheryl Lyn Walker & W. Kimryn Rathmell. (2020) Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nature Reviews Nephrology 17:4, pages 245-261.
Crossref
Crossref
Minqian Shen, Mengyang Xu, Fanyi Zhong, McKenzie C. Crist, Anjali B. Prior, Kundi Yang, Danielle M. Allaire, Fouad Choueiry, Jiangjiang Zhu & Haifei Shi. (2021) A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2. Cells 10:2, pages 455.
Crossref
Crossref
Cen Zhang, Juan Liu, Jianming Wang, Tianliang Zhang, Dandan Xu, Wenwei Hu & Zhaohui Feng. (2021) The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Lennart Brewitz, Yu Nakashima & Christopher J. Schofield. (2021) Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase. Chemical Science 12:4, pages 1327-1342.
Crossref
Crossref
Scott S. Hannah, Sonyia McFadden, Andrea McNeilly & Conor McClean. (2020) “Take My Bone Away?” Hypoxia and bone: A narrative review. Journal of Cellular Physiology 236:2, pages 721-740.
Crossref
Crossref
Qinhan Li, Zhenan Zhang, Yu Fan & Qian Zhang. (2021) Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications. Frontiers in Genetics 11.
Crossref
Crossref
Martina Takacova & Silvia Pastorekova. 2021. The Carbonic Anhydrases: Current and Emerging Therapeutic Targets. The Carbonic Anhydrases: Current and Emerging Therapeutic Targets
147
178
.
Meaghan Torvund, Jayati Chakrabarti & Yana Zavros. 2021. Inflammation, Infection, and Microbiome in Cancers. Inflammation, Infection, and Microbiome in Cancers
155
197
.
Antonio Bouthelier, Florinda Meléndez-Rodríguez, Andrés A. Urrutia & Julián Aragonés. (2020) Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity. International Journal of Molecular Sciences 21:24, pages 9401.
Crossref
Crossref
Pai-Sheng Chen, Wen-Tai Chiu, Pei-Ling Hsu, Shih-Chieh Lin, I-Chen Peng, Chia-Yih Wang & Shaw-Jenq Tsai. (2020) Pathophysiological implications of hypoxia in human diseases. Journal of Biomedical Science 27:1.
Crossref
Crossref
Sylwia Bartoszewska & James F. Collawn. (2020) Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia. Cellular & Molecular Biology Letters 25:1.
Crossref
Crossref
Julie-Aurore Losman, Peppi Koivunen & William G. KaelinJr.Jr.. (2020) 2-Oxoglutarate-dependent dioxygenases in cancer. Nature Reviews Cancer 20:12, pages 710-726.
Crossref
Crossref
Adam Kowalewski, Marek Zdrenka, Dariusz Grzanka & Łukasz Szylberg. (2020) Targeting the Deterministic Evolutionary Trajectories of Clear Cell Renal Cell Carcinoma. Cancers 12:11, pages 3300.
Crossref
Crossref
Ashutosh Tiwari, Kojiro Tashiro, Ajay Dixit, Aditi Soni, Keianna Vogel, Bryan Hall, Iram Shafqat, Joseph Slaughter, Nesteen Param, An Le, Emily Saunders, Utkarsha Paithane, Guillermina Garcia, Alexandre Rosa Campos, Jon Zettervall, Marjorie Carlson, Timothy K. Starr, York Marahrens, Aniruddha J. Deshpande, Cosimo Commisso, Paolo P. Provenzano & Anindya Bagchi. (2020) Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. Gastroenterology 159:5, pages 1882-1897.e5.
Crossref
Crossref
Niraj Shenoy. (2020) HIF1α is not a target of 14q deletion in clear cell renal cancer. Scientific Reports 10:1.
Crossref
Crossref
Toni K. Choueiri & William G. KaelinJrJr. (2020) Targeting the HIF2–VEGF axis in renal cell carcinoma. Nature Medicine 26:10, pages 1519-1530.
Crossref
Crossref
Zachary A. Bacigalupa & W. Kimryn Rathmell. (2020) Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma. Cancer Letters 489, pages 19-28.
Crossref
Crossref
Xiaoyu Sun, Xuemei Lv, Yuanyuan Yan, Yanyun Zhao, Rong Ma, Miao He & Minjie Wei. (2020) Hypoxia-mediated cancer stem cell resistance and targeted therapy. Biomedicine & Pharmacotherapy 130, pages 110623.
Crossref
Crossref
Sophie J. Cowman, Daniel G. Fuja, Xian-De Liu, Rebecca S. Slack Tidwell, Neelima Kandula, Deepika Sirohi, Archana M. Agarwal, Lyska L. Emerson, Sheryl R. Tripp, Jeffrey S. Mohlman, Miekan Stonhill, Guillermina Garcia, Christopher J. Conley, Adam A. Olalde, Timothy Sargis, Adela Ramirez-Torres, Jose A. Karam, Christopher G. Wood, Kanishka Sircar, Pheroze Tamboli, Kenneth Boucher, Benjamin Maughan, Benjamin T. Spike, Thai H. Ho, Neeraj Agarwal, Eric Jonasch & Mei Yee Koh. (2020) Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer. Clinical Cancer Research 26:18, pages 4970-4982.
Crossref
Crossref
Yanting Luo, Louise Medina Bengtsson, Xuechun Wang, Tianhe Huang, Guoqiang Liu, Sean Murphy, Caiqin Wang, John KorenIIIIII, Zachary Schafer & Xin Lu. (2020) UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells. Scientific Reports 10:1.
Crossref
Crossref
Roy Elias, Qing Zhang & James Brugarolas. (2020) The von Hippel-Lindau Tumor Suppressor Gene. The Cancer Journal 26:5, pages 390-398.
Crossref
Crossref
Christian R. Hoerner, Susanna Y. Miao, James J. Hsieh & Alice C. Fan. (2020) Targeting Metabolic Pathways in Kidney Cancer. The Cancer Journal 26:5, pages 407-418.
Crossref
Crossref
Antonio Bouthelier & Julián Aragonés. (2020) Role of the HIF oxygen sensing pathway in cell defense and proliferation through the control of amino acid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1867:9, pages 118733.
Crossref
Crossref
Y. Gao, G. J. Khan, X. Wei, K.-F. Zhai, L. Sun & S. Yuan. (2020) DT-13 inhibits breast cancer cell migration via non-muscle myosin II-A regulation in tumor microenvironment synchronized adaptations. Clinical and Translational Oncology 22:9, pages 1591-1602.
Crossref
Crossref
Rouven Hoefflin, Sabine Harlander, Silvia Schäfer, Patrick Metzger, Fengshen Kuo, Désirée Schönenberger, Mojca Adlesic, Asin Peighambari, Philipp Seidel, Chia-yi Chen, Miguel Consenza-Contreras, Andreas Jud, Bernd Lahrmann, Niels Grabe, Danijela Heide, Franziska M. Uhl, Timothy A. Chan, Justus Duyster, Robert Zeiser, Christoph Schell, Mathias Heikenwalder, Oliver Schilling, A. Ari Hakimi, Melanie Boerries & Ian J. Frew. (2020) HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice. Nature Communications 11:1.
Crossref
Crossref
Chiara Corrado & Simona Fontana. (2020) Hypoxia and HIF Signaling: One Axis with Divergent Effects. International Journal of Molecular Sciences 21:16, pages 5611.
Crossref
Crossref
Sascha R.A. Alles, Kimberly Gomez, Aubin Moutal & Rajesh Khanna. (2020) Putative roles of SLC7A5 (LAT1) transporter in pain. Neurobiology of Pain 8, pages 100050.
Crossref
Crossref
Kinga Pajdzik, Mateusz Wilamowski, Dariusz Żurawek, Kinga B. Stopa, Michał Nodzyński, Agata Kalita & Jolanta Jura. (2020) Anterior gradient 2 promotes tumorigenesis through upregulation of CCAAT‐enhancer binding protein beta and hypoxia‐inducible factor‐2α and subsequent secretion of interleukin‐6, interleukin‐8, and vascular endothelial growth factor in the Caki‐1 clear cell renal cell carcinoma cell line. IUBMB Life 72:8, pages 1807-1818.
Crossref
Crossref
Tanja Eberhart, Miriam J. Schönenberger, Katharina M. Walter, Khanichi N. Charles, Phyllis L. Faust & Werner J. Kovacs. (2020) Peroxisome-Deficiency and HIF-2α Signaling Are Negative Regulators of Ketohexokinase Expression. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Minghua Li, Jing Li, Xiaofang Guo, Hua Pan & Qingyu Zhou. (2020) Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress. Cancers 12:6, pages 1538.
Crossref
Crossref
Kai HongLianxin Hu, Xijuan LiuJeremy M. Simon, Travis S. Ptacek, Xingnan Zheng, Chengheng Liao, Albert S. BaldwinQing Zhang. (2020) USP37 promotes deubiquitination of HIF2α in kidney cancer. Proceedings of the National Academy of Sciences 117:23, pages 13023-13032.
Crossref
Crossref
Yajuan J. Liu, Jane Houldsworth, Rajyasree Emmadi, Lisa Dyer & Daynna J. Wolff. (2020) Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genetics 244, pages 40-54.
Crossref
Crossref
Juan Chen, Yanjun Shen, Jing Wang, Gang Ouyang, Jingliang Kang, Wenqi Lv, Liandong Yang & Shunping He. (2020) Analysis of Multiplicity of Hypoxia-Inducible Factors in the Evolution of Triplophysa Fish (Osteichthyes: Nemacheilinae) Reveals Hypoxic Environments Adaptation to Tibetan Plateau. Frontiers in Genetics 11.
Crossref
Crossref
Liangsong Zhu, Rong Ding, Hao Yan, Jin Zhang & Zongming Lin. (2020) ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma. Cell Death & Disease 11:5.
Crossref
Crossref
Keun-Tae Park, Jong-Kwon Han, Seong Jin Kim & Young-Hee Lim. (2020) Gamma-Aminobutyric Acid Increases Erythropoietin by Activation of Citrate Cycle and Stimulation of Hypoxia-Inducible Factors Expression in Rats. Biomolecules 10:4, pages 595.
Crossref
Crossref
Philip S Macklin, Atsushi Yamamoto, Lisa Browning, Monika Hofer, Julie Adam & Christopher W Pugh. (2020) Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue‐based research. The Journal of Pathology 250:5, pages 593-611.
Crossref
Crossref
Xinxin Liu, Xiaoli Zhang, Zhiqiang Peng, Chunnan Li, Ze Wang, Chanjuan Wang, Zhikang Deng, Bo Wu, Yu Cui, Zhanxin Wang, Chun‐Ping Cui, Min Zheng & Lingqiang Zhang. (2020) Deubiquitylase OTUD6B Governs pVHL Stability in an Enzyme‐Independent Manner and Suppresses Hepatocellular Carcinoma Metastasis. Advanced Science 7:8, pages 1902040.
Crossref
Crossref
Xiaotong Cheng, Maria Prange-Barczynska, James W. Fielding, Minghao Zhang, Alana L. Burrell, Joanna D.C.C. Lima, Luise Eckardt, Isobel L.A. Argles, Christopher W. Pugh, Keith J. Buckler, Peter A. Robbins, Emma J. Hodson, Richard K. Bruick, Lucy M. Collinson, Fraydoon Rastinejad, Tammie Bishop & Peter J. Ratcliffe. (2020) Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control. Journal of Clinical Investigation 130:5, pages 2237-2251.
Crossref
Crossref
Juan Manuel Martí, Mónica Fernández-Cortés, Santiago Serrano-Sáenz, Esteban Zamudio-Martinez, Daniel Delgado-Bellido, Angel Garcia-Diaz & Francisco Javier Oliver. (2020) The Multifactorial Role of PARP-1 in Tumor Microenvironment. Cancers 12:3, pages 739.
Crossref
Crossref
Chang-Cheng Zhao, Wen-Wei Yu, Ying-Jie Qi, Liang-Fei Xu, Zi-Ran Wang, Ya-Wen Qiang, Fan Ma & Xiao-Ling Ma. (2020) Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells. Anti-Cancer Drugs 31:3, pages 223-230.
Crossref
Crossref
Victoria Lauer, Steffen Grampp, James Platt, Veronique Lafleur, Olivia Lombardi, Hani Choudhry, Franziska Kranz, Arndt Hartmann, Bernd Wullich, Atsushi Yamamoto, Mathew L. Coleman, Peter J. Ratcliffe, David R. Mole & Johannes Schödel. (2020) Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI. Journal of Biological Chemistry 295:13, pages 4065-4078.
Crossref
Crossref
Paweł Sobczuk, Anna Brodziak, Mohammed Imran Khan, Stuti Chhabra, Michał Fiedorowicz, Marlena Wełniak-Kamińska, Kamil Synoradzki, Ewa Bartnik, Agnieszka Cudnoch-Jędrzejewska & Anna M. Czarnecka. (2020) Choosing The Right Animal Model for Renal Cancer Research. Translational Oncology 13:3, pages 100745.
Crossref
Crossref
Horacio Gomez-Acevedo, Yuemeng Dai, Graham Strub, Carrie Shawber, June K. Wu & Gresham T. Richter. (2020) Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration. Scientific Reports 10:1.
Crossref
Crossref
Kevin D. Courtney, Yuanqing Ma, Alberto Diaz de Leon, Alana Christie, Zhiqun Xie, Layton Woolford, Nirmish Singla, Allison Joyce, Haley Hill, Ananth J. Madhuranthakam, Qing Yuan, Yin Xi, Yue Zhang, Jenny Chang, Oluwatomilade Fatunde, Yull Arriaga, Arthur E. Frankel, Sanjeeva Kalva, Song Zhang, Tiffani McKenzie, Oscar Reig Torras, Robert A. Figlin, Brian I. Rini, Renée M. McKay, Payal Kapur, Tao Wang, Ivan Pedrosa & James Brugarolas. (2020) HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma. Clinical Cancer Research 26:4, pages 793-803.
Crossref
Crossref
D Whiting & S Sriprasad. (2019) Molecular biology and targeted therapy in metastatic renal cell carcinoma. Journal of Clinical Urology 13:1, pages 40-49.
Crossref
Crossref
Koen M. A. Dreijerink, Rachel S. van Leeuwaarde, Wenzel M. Hackeng, Rachel H. Giles, Wendy W. J. de Leng, Paul C. Jutte, Albert J. H. Suurmeijer, Bernadette P. M. van Nesselrooij & Lodewijk A. A. Brosens. (2019) Clear cell chondrosarcoma in Von Hippel-Lindau disease. Familial Cancer 19:1, pages 41-45.
Crossref
Crossref
Virginia Schmid, Veronique N. Lafleur, Olivia Lombardi, Ran Li, Rafik Salama, Leandro Colli, Hani Choudhry, Stephen Chanock, Peter J. Ratcliffe & David R. Mole. (2019) Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer. Scientific Reports 9:1.
Crossref
Crossref
Qing Zhang, Jian-He Liu, Jing-Li Liu, Chun-Ting Qi, Lei Yan, Yu Chen & Qiang Yu. (2019) Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas. BMC Cancer 19:1.
Crossref
Crossref
Yuree Byun, Young-Chul Choi, Yunhui Jeong, Gangtae Lee, Sena Yoon, Yongsu Jeong, Jaeseung Yoon & Kwanghee Baek. (2019) MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells. Cellular & Molecular Biology Letters 24:1.
Crossref
Crossref
Eamonn R Maher & Richard N Sandford. (2019) von Hippel-Lindau Disease: an Update. Current Genetic Medicine Reports 7:4, pages 227-235.
Crossref
Crossref
Joachim Fandrey, Johannes Schödel, Kai-Uwe Eckardt, Dörthe M. Katschinski & Roland H. Wenger. (2019) Now a Nobel gas: oxygen. Pflügers Archiv - European Journal of Physiology 471:11-12, pages 1343-1358.
Crossref
Crossref
Johannes Schödel & Peter J. Ratcliffe. (2019) Mechanisms of hypoxia signalling: new implications for nephrology. Nature Reviews Nephrology 15:10, pages 641-659.
Crossref
Crossref
Lorenza Bacci, Aurora Aiello, Cristian Ripoli, Rossella Loria, Dario Pugliese, Francesco Pierconti, Dante Rotili, Lidia Strigari, Francesco Pinto, Pier Francesco Bassi, Antonello Mai, Claudio Grassi, Alfredo Pontecorvi, Rita Falcioni, Antonella Farsetti & Simona Nanni. (2019) H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. International Journal of Molecular Sciences 20:16, pages 4012.
Crossref
Crossref
Hui Yang, Yue‐Hang Geng, Peng Wang, Yan‐Ting Zhou, Han Yang, Yan‐Fei Huo, Hong‐Quan Zhang, Yan Li, Hui‐Ying He, Xin‐Xia Tian & Wei‐Gang Fang. (2019) Extracellular ATP promotes breast cancer invasion and epithelial‐mesenchymal transition via hypoxia‐inducible factor 2α signaling. Cancer Science 110:8, pages 2456-2470.
Crossref
Crossref
Nathanael H. Green, Daniel L. Galvan, Shawn S. Badal, Benny H. Chang, Valerie S. LeBleu, Jianyin Long, Eric Jonasch & Farhad R. Danesh. (2019) MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma. Oncogene 38:34, pages 6211-6225.
Crossref
Crossref
Murali Dharan Bashyam, Srinivas Animireddy, Pratyusha Bala, Ashmala Naz & Sara Anisa George. (2019) The Yin and Yang of cancer genes. Gene 704, pages 121-133.
Crossref
Crossref
Piotr Wierzbicki, Jakub Klacz, Anna Kotulak‑Chrzaszcz, Agata Wronska, Marcin Stanislawowski, Agnieszka Rybarczyk, Aleksandra Ludziejewska, Zbigniew Kmiec & Marcin Matuszewski. (2019) Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment. International Journal of Oncology.
Crossref
Crossref
Sun Young Lee, Ka Hyon Park, Hyung-Gu Yu, Eunbyul Kook, Won-Hyun Song, Gyuseok Lee, Jeong-Tae Koh, Hong-In Shin, Je-Yong Choi, Yun Hyun Huh & Je-Hwang Ryu. (2019) Controlling hypoxia-inducible factor-2α is critical for maintaining bone homeostasis in mice. Bone Research 7:1.
Crossref
Crossref
Ying Xiong, Li Liu, Yu Xia, Yangyang Qi, Yifan Chen, Lingli Chen, Peipei Zhang, Yunyi Kong, Yang Qu, Zewei Wang, Zhiyuan Lin, Xiang Chen, Zhuoyi Xiang, Jiajun Wang, Qi Bai, Weijuan Zhang, Yuanfeng Yang, Jianming Guo & Jiejie Xu. (2019) Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma. Cancer Immunology, Immunotherapy 68:5, pages 731-741.
Crossref
Crossref
Silvina Beatriz Meroni, María Noel Galardo, Gustavo Rindone, Agostina Gorga, María Fernanda Riera & Selva Beatriz Cigorraga. (2019) Molecular Mechanisms and Signaling Pathways Involved in Sertoli Cell Proliferation. Frontiers in Endocrinology 10.
Crossref
Crossref
Diego Camuzi, Ísis de Amorim, Luis Ribeiro Pinto, Leonardo Oliveira Trivilin, André Mencalha & Sheila Soares Lima. (2019) Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer. Cells 8:4, pages 300.
Crossref
Crossref
Dong Ryeol Ryu, Mi Ra Yu, Kyoung Hye Kong, Hyoungnae Kim, Soon Hyo Kwon, Jin Seok Jeon, Dong Cheol Han & Hyunjin Noh. (2019) Sirt1-hypoxia-inducible factor-1α interaction is a key mediator of tubulointerstitial damage in the aged kidney. Aging Cell 18:2, pages e12904.
Crossref
Crossref
Shuai Yuan, Ying Xiang, Guilu Wang, Meiyu Zhou, Gang Meng, Qingyun Liu, Zeyao Hu, Chengying Li, Weijia Xie, Na Wu, Long Wu, Tongjian Cai, Xiangyu Ma, Yao Zhang, Zubin Yu, Li Bai & Yafei Li. (2019)
Hypoxia‐sensitive
LINC
01436 is regulated by E2F6 and acts as an oncogene by targeting miR‐30a‐3p in non‐small cell lung cancer
. Molecular Oncology 13:4, pages 840-856.
Crossref
Crossref
Mazhar Pasha, Siveen K. Sivaraman, Ronald Frantz, Abdelali Agouni & Shankar Munusamy. (2019) Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines. Biomolecules 9:3, pages 113.
Crossref
Crossref
Petra Miikkulainen, Heidi Högel, Fatemeh Seyednasrollah, Krista Rantanen, Laura L. Elo & Panu M. Jaakkola. (2019) Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma. Journal of Biological Chemistry 294:10, pages 3760-3771.
Crossref
Crossref
Tsai-Kun Wu, Chyou-Wei Wei, Ying-Ru Pan, Ren-Jun Hsu, Chung-Yi Wu & Yung-Luen Yu. (2019) The uremic toxin p-cresyl sulfate induces proliferation and migration of clear cell renal cell carcinoma via microRNA-21/ HIF-1α axis signals. Scientific Reports 9:1.
Crossref
Crossref
Cailin Wilson & Adam J. Krieg. (2019) KDM4B: A Nail for Every Hammer?. Genes 10:2, pages 134.
Crossref
Crossref
Florinda Meléndez-Rodríguez, Andrés A. Urrutia, Doriane Lorendeau, Gianmarco Rinaldi, Olga Roche, Nuray Böğürcü-Seidel, Marta Ortega Muelas, Claudia Mesa-Ciller, Guillermo Turiel, Antonio Bouthelier, Pablo Hernansanz-Agustín, Ainara Elorza, Elia Escasany, Qilong Oscar Yang Li, Mar Torres-Capelli, Daniel Tello, Esther Fuertes, Enrique Fraga, Antonio Martínez-Ruiz, Belen Pérez, Jose Miguel Giménez-Bachs, Antonio S. Salinas-Sánchez, Till Acker, Ricardo Sánchez Prieto, Sarah-Maria Fendt, Katrien De Bock & Julián Aragonés. (2019) HIF1α Suppresses Tumor Cell Proliferation through Inhibition of Aspartate Biosynthesis. Cell Reports 26:9, pages 2257-2265.e4.
Crossref
Crossref
John C. Chappell, Laura Beth Payne & W. Kimryn Rathmell. (2019) Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers. Journal of Clinical Investigation 129:2, pages 442-451.
Crossref
Crossref
James A Smythies, Min Sun, Norma Masson, Rafik Salama, Peter D Simpson, Elizabeth Murray, Viviana Neumann, Matthew E Cockman, Hani Choudhry, Peter J Ratcliffe & David R Mole. (2018)
Inherent
DNA
‐binding specificities of the
HIF
‐1α and
HIF
‐2α transcription factors in chromatin
. EMBO reports 20:1.
Crossref
Crossref
Moe Ishihara, Junhui Hu, Anthony Wong, Celine Cano-Ruiz & Lily Wu. 2019. Chick Chorioallantoic Membrane Model and Precision Cancer Therapy. Chick Chorioallantoic Membrane Model and Precision Cancer Therapy
59
80
.
Jaleh Fallah & Brian I. Rini. (2019) HIF Inhibitors: Status of Current Clinical Development. Current Oncology Reports 21:1.
Crossref
Crossref
Michael John KerinsAikseng Ooi. (2018) The Roles of NRF2 in Modulating Cellular Iron Homeostasis. Antioxidants & Redox Signaling 29:17, pages 1756-1773.
Crossref
Crossref
Hayriye Tatli Dogan, Merve Kiran, Burak Bilgin, Aydan Kiliçarslan, Mehmet Ali Nahit Sendur, Bülent Yalçin, Arslan Ardiçoglu, Ali Fuat Atmaca & Berrak Gumuskaya. (2018) Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression. Diagnostic Pathology 13:1.
Crossref
Crossref
Bo Zhang, Hua Ye & Aidong Yang. (2018) Mathematical modelling of interacting mechanisms for hypoxia mediated cell cycle commitment for mesenchymal stromal cells. BMC Systems Biology 12:1.
Crossref
Crossref
Hannah Harrison, Henry J. Pegg, Jamie Thompson, Christian Bates & Paul Shore. (2018) HIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells. BMC Cancer 18:1.
Crossref
Crossref
Peppi Koivunen & Thomas Kietzmann. (2018) Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism. Trends in Molecular Medicine 24:12, pages 1021-1035.
Crossref
Crossref
Christina Befani & Panagiotis Liakos. (2018) The role of hypoxia‐inducible factor‐2 alpha in angiogenesis. Journal of Cellular Physiology 233:12, pages 9087-9098.
Crossref
Crossref
Christina Wohlrab, Margreet C. M. Vissers, Elisabeth Phillips, Helen Morrin, Bridget A. Robinson & Gabi U. Dachs. (2018) The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein. Frontiers in Oncology 8.
Crossref
Crossref
Xin Fang, Ru Sun, Yuxin Hu, Huihui Wang, Yi Guo, Bei Yang, Jingbo Pi & Yuanyuan Xu. (2018)
miRNA-182-5p
,
via HIF2α
, contributes to arsenic carcinogenesis: evidence from human renal epithelial cells
. Metallomics 10:11, pages 1607-1617.
Crossref
Crossref
Alexander Greenhough, Clare Bagley, Kate J Heesom, David B Gurevich, David Gay, Mark Bond, Tracey J Collard, Chris Paraskeva, Paul Martin, Owen J Sansom, Karim Malik & Ann C Williams. (2018) Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis. EMBO Molecular Medicine 10:11.
Crossref
Crossref
Anders P. Mutvei, Sebastian K.-J. Landor, Rhys Fox, Eike-Benjamin Braune, Yat Long Tsoi, Yee Peng Phoon, Cecilia Sahlgren, Johan Hartman, Jonas Bergh, Shaobo Jin & Urban Lendahl. (2018) Notch signaling promotes a HIF2α-driven hypoxic response in multiple tumor cell types. Oncogene 37:46, pages 6083-6095.
Crossref
Crossref
Youcef Rustum, Sreenivasulu Chintala, Farukh Durrani & Arup Bhattacharya. (2018) Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma—Bench-to-Bedside Therapy. International Journal of Molecular Sciences 19:11, pages 3378.
Crossref
Crossref
Minqian Shen, Jingyi Cao & Haifei Shi. (2018) Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing. International Journal of Endocrinology 2018, pages 1-16.
Crossref
Crossref
Thomas Briston, Jenna M. Stephen, Luke W. Thomas, Cinzia Esposito, Yuen-Li Chung, Saiful E. Syafruddin, Mark Turmaine, Lucas A. Maddalena, Basma Greef, Gyorgy Szabadkai, Patrick H. Maxwell, Sakari Vanharanta & Margaret Ashcroft. (2018) VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function. Frontiers in Oncology 8.
Crossref
Crossref
Martin Schläpfer. (2018) Ist Sauerstoffmangel immer nur schädlich?. Praxis 107:21, pages 1155-1159.
Crossref
Crossref
Joaquín Araos, Jonathan P. Sleeman & Boyan K. Garvalov. (2018) The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies. Clinical & Experimental Metastasis 35:7, pages 563-599.
Crossref
Crossref
Valeria Righi, María-Luisa García-Martín, Adele Mucci, Luisa Schenetti, Vitaliano Tugnoli, Pilar Lopez-Larrubia & Sebastián Cerdán. (2018) Spatially Resolved Bioenergetic and Genetic Reprogramming Through the Brain of Rats Bearing Implanted C6 Gliomas As Detected by Multinuclear High-Resolution Magic Angle Spinning and Genomic Analysis. Journal of Proteome Research 17:9, pages 2953-2962.
Crossref
Crossref
Lucile Broncy & Patrizia Paterlini-Bréchot. (2018) Circulating Tumor Cells for the Management of Renal Cell Carcinoma. Diagnostics 8:3, pages 63.
Crossref
Crossref
Agostina Gorga, Gustavo Rindone, Mariana Regueira, María Fernanda Riera, Eliana Herminia Pellizzari, Selva Beatriz Cigorraga, Silvina Beatriz Meroni & María Noel Galardo. (2018) HIF involvement in the regulation of rat Sertoli cell proliferation by FSH. Biochemical and Biophysical Research Communications 502:4, pages 508-514.
Crossref
Crossref
Danielle J. Sanchez & M. Celeste Simon. (2018) Genetic and metabolic hallmarks of clear cell renal cell carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1870:1, pages 23-31.
Crossref
Crossref
Sophie C. Joosten, Kim M. Smits, Maureen J. Aarts, Veerle Melotte, Alexander Koch, Vivianne C. Tjan-Heijnen & Manon van Engeland. (2018) Epigenetics in renal cell cancer: mechanisms and clinical applications. Nature Reviews Urology 15:7, pages 430-451.
Crossref
Crossref
Florinda Meléndez-Rodríguez, Olga Roche, Ricardo Sanchez-Prieto & Julian Aragones. (2018) Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel–Lindau-Deficient Renal Cancer. Frontiers in Oncology 8.
Crossref
Crossref
Markus ThierschErik R. Swenson. (2018) High Altitude and Cancer Mortality. High Altitude Medicine & Biology 19:2, pages 116-123.
Crossref
Crossref
Patrick Pilié, Elshad Hasanov, Surena F. Matin, Ashley H. Henriksen Woodson, Valerie D. Marcott, Shelly Bird, Rebecca S. Slack, Gregory N. Fuller, Ian E. McCutcheon & Eric Jonasch. (2018) Pilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget 9:34, pages 23390-23395.
Crossref
Crossref
David Macias, Andrew S Cowburn, Hortensia Torres-Torrelo, Patricia Ortega-Sáenz, José López-Barneo & Randall S Johnson. (2018) HIF-2α is essential for carotid body development and function. eLife 7.
Crossref
Crossref
William G. KaelinJrJr. (2018) HIF2 Inhibitor Joins the Kidney Cancer Armamentarium. Journal of Clinical Oncology 36:9, pages 908-910.
Crossref
Crossref
William G. Kaelin. (2018) The von Hippel–Lindau Tumor Suppressor Protein. Annual Review of Cancer Biology 2:1, pages 91-109.
Crossref
Crossref
Margaret E. TorrenceBrendan D. Manning. (2018) Nutrient Sensing in Cancer. Annual Review of Cancer Biology 2:1, pages 251-269.
Crossref
Crossref
Andrea Fabianova, Monika Barathova, Lucia Csaderova, Veronika Simko, Miriam Zatovicova, Martina Labudova & Jaromir Pastorek. (2018) Hypoxic marker CA IX and adhesion mediator β-catenin are downregulated by lymphocytic choriomeningitis virus persistent infection. Oncotarget 9:16, pages 12879-12893.
Crossref
Crossref
Displaying 200 of 705 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list